It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Familial Parkinson’s disease (PD) protein DJ-1 mutations are linked to early onset PD. We have found that DJ-1 binds directly to the F1FO ATP synthase β subunit. DJ-1’s interaction with the β subunit decreased mitochondrial uncoupling and enhanced ATP production efficiency while in contrast mutations in DJ-1 or DJ-1 knockout increased mitochondrial uncoupling, and depolarized neuronal mitochondria. In mesencephalic DJ-1 KO cultures, there was a progressive loss of neuronal process extension. This was ameliorated by a pharmacological reagent, dexpramipexole, that binds to ATP synthase, closing a mitochondrial inner membrane leak and enhancing ATP synthase efficiency. ATP synthase c-subunit can form an uncoupling channel; we measured, therefore, ATP synthase F1 (β subunit) and c-subunit protein levels. We found that ATP synthase β subunit protein level in the DJ-1 KO neurons was approximately half that found in their wild-type counterparts, comprising a severe defect in ATP synthase stoichiometry and unmasking c-subunit. We suggest that DJ-1 enhances dopaminergic cell metabolism and growth by its regulation of ATP synthase protein components.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Department of Internal Medicine (Endocrinology), Yale University, New Haven, CT, USA
2 Department of Internal Medicine (Endocrinology), Yale University, New Haven, CT, USA; Department of Human Nutrition and Hospitality Management, University of Alabama, Tuscaloosa, AL, USA
3 Department of Cell Biology, Yale University, New Haven, CT, USA
4 Department of Neurology, Erasmus MC, Rotterdam, The Netherlands
5 Neurology Service and Stroke Unit, Brotzu General Hospital, Cagliari, Italy
6 Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands
7 Institute of Life Sciences, University of Southampton, Southampton, England; Marine Biological Laboratory, Woods Hole, MA, USA
8 Marine Biological Laboratory, Woods Hole, MA, USA; Division of Brain Sciences, Department of Medicine, Imperial College, London, UK
9 Department of Internal Medicine (Endocrinology), Yale University, New Haven, CT, USA; Marine Biological Laboratory, Woods Hole, MA, USA; Department of Neuroscience, Yale University, New Haven, CT, USA